Portola is a global biotechnology company charting a new course in the treatment of serious blood-related disorders.
Our dedication to unconventional exploration and discovery has yielded unique proprietary medicines that fundamentally shift how patients with thrombotic and other hematologic disorders are treated.
By combining our expertise and passion with a persistent focus on the discovery and development of novel compounds, we strive to make a significant impact on the lives of patients around the world.
270 East Grand Avenue
South San Francisco, CA 94080